Christopher James Waddick - Net Worth and Insider Trading
Christopher James Waddick Net Worth
The estimated net worth of Christopher James Waddick is at least $305,800 dollars as of 2024-11-10. Christopher James Waddick is the Director, Senior Officer of Cardiol Therapeutics Inc and owns about 110,000 shares of Cardiol Therapeutics Inc (TSX:CRDL) stock worth over $305,800. Details can be seen in Christopher James Waddick's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher James Waddick has not made any transactions after 2019-10-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher James Waddick
Christopher James Waddick Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher James Waddick owns 1 companies in total, including Cardiol Therapeutics Inc (TSX:CRDL) .
Click here to see the complete history of Christopher James Waddick’s form 4 insider trades.
Insider Ownership Summary of Christopher James Waddick
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-15 | Director & Senior Officer |
Christopher James Waddick Latest Holdings Summary
Christopher James Waddick currently owns a total of 1 stock. Christopher James Waddick owns 110,000 shares of Cardiol Therapeutics Inc (TSX:CRDL) as of October 15, 2019, with a value of $305,800.
Latest Holdings of Christopher James Waddick
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:CRDL | Cardiol Therapeutics Inc | 2019-10-15 | 110,000 | 2.78 | 305,800 |
Holding Weightings of Christopher James Waddick
Christopher James Waddick Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher James Waddick has made a total of 0 transactions in Cardiol Therapeutics Inc (TSX:CRDL) over the past 5 years. The most-recent trade in Cardiol Therapeutics Inc is the acquisition of 10,000 shares on October 15, 2019, which cost Christopher James Waddick around $27,200.
Insider Trading History of Christopher James Waddick
- 1
Christopher James Waddick Trading Performance
GuruFocus tracks the stock performance after each of Christopher James Waddick's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher James Waddick is 47.26%. GuruFocus also compares Christopher James Waddick's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher James Waddick within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher James Waddick's insider trading performs compared to the benchmark.
Performance of Christopher James Waddick
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -14.38 | | | | | |
| Relative Return to S&P 500(%) | -18.55 | | | | | |
Christopher James Waddick Ownership Network
Ownership Network List of Christopher James Waddick
Ownership Network Relation of Christopher James Waddick
Christopher James Waddick Owned Company Details
What does Cardiol Therapeutics Inc do?
Who are the key executives at Cardiol Therapeutics Inc?
Christopher James Waddick is the Director & Senior Officer of Cardiol Therapeutics Inc. Other key executives at Cardiol Therapeutics Inc include Senior Officer Guillermo Torre , and Director & Senior Officer David Elsley .
Cardiol Therapeutics Inc (TSX:CRDL) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cardiol Therapeutics Inc (TSX:CRDL) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Cardiol Therapeutics Inc (TSX:CRDL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cardiol Therapeutics Inc Insider Transactions
Christopher James Waddick Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher James Waddick. Currently GuruFocus does not have mailing address information for Christopher James Waddick.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
